{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:23:36Z","timestamp":1759332216370},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1007\/s00347-007-1534-9","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T18:48:16Z","timestamp":1176922096000},"page":"425-430","source":"Crossref","is-referenced-by-count":3,"title":["Therapie des zystoiden Makula\u00f6dems bei Pseudophakie"],"prefix":"10.1007","volume":"104","author":[{"given":"H.T.","family":"Agostini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.L.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Feltgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1534_CR1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9394(02)01938-4","volume":"135","author":"Benhamou","year":"2003","unstructured":"Benhamou N, Massin P, Haouchine B et al. (2003) Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 135: 246\u2013249","journal-title":"Am J Ophthalmol"},{"key":"1534_CR2","doi-asserted-by":"crossref","unstructured":"Bolz M, Michels S, Geitzenauer W et al. (2006) Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment. Br J Ophthalmol [Epub ahead of print]","DOI":"10.1136\/bjo.2006.102467"},{"key":"1534_CR3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00006982-198808030-00001","volume":"8","author":"Bradford","year":"1988","unstructured":"Bradford JD, Wilkinson CP, Bradford RH Jr. (1988) Cystoid macular edema following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Retina 8: 161\u2013164","journal-title":"Retina"},{"key":"1534_CR4","doi-asserted-by":"crossref","unstructured":"Cordero CM, Sobrin L, Onal S et al. (2007) Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology [Epub ahead of print]","DOI":"10.1016\/j.ophtha.2006.11.028"},{"key":"1534_CR5","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archopht.1988.01060140350030","volume":"106","author":"Cox","year":"1988","unstructured":"Cox SN, Hay E, Bird AC (1988) Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 106: 1190\u20131195","journal-title":"Arch Ophthalmol"},{"key":"1534_CR6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/bjo.78.1.4","volume":"78","author":"Farber","year":"1994","unstructured":"Farber MD, Lam S, Tessler HH et al. (1994) Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study. Br J Ophthalmol 78: 4\u20137","journal-title":"Br J Ophthalmol"},{"key":"1534_CR7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/archopht.1989.01070010172003","volume":"107","author":"Flach","year":"1989","unstructured":"Flach AJ (1989) Cystoid macular edema following cataract surgery. Arch Ophthalmol 107: 166\u2013167","journal-title":"Arch Ophthalmol"},{"key":"1534_CR8","first-page":"557","volume":"96","author":"Flach","year":"1998","unstructured":"Flach AJ (1998) The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 96: 557\u2013634","journal-title":"Trans Am Ophthalmol Soc"},{"key":"1534_CR9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0002-9394(14)74268-0","volume":"103","author":"Flach","year":"1987","unstructured":"Flach AJ, Dolan BJ, Irvine AR (1987) Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Am J Ophthalmol 103: 479\u2013486","journal-title":"Am J Ophthalmol"},{"key":"1534_CR10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archopht.1988.01060130370024","volume":"106","author":"Flach","year":"1988","unstructured":"Flach AJ, Graham J, Kruger LP et al. (1988) Quantitative assessment of postsurgical breakdown of the blood-aqueous barrier following administration of 0.5% ketorolac tromethamine solution. A double-masked, paired comparison with vehicle-placebo solution study. Arch Ophthalmol 106: 344\u2013347","journal-title":"Arch Ophthalmol"},{"key":"1534_CR11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0002-9394(14)76851-5","volume":"112","author":"Flach","year":"1991","unstructured":"Flach AJ, Jampol LM, Weinberg D et al. (1991) Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol 112: 514\u2013519","journal-title":"Am J Ophthalmol"},{"key":"1534_CR12","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0161-6420(90)32423-5","volume":"97","author":"Flach","year":"1990","unstructured":"Flach AJ, Stegman RC, Graham J et al. (1990) Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology 97: 1253\u20131258","journal-title":"Ophthalmology"},{"key":"1534_CR13","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0161-6420(85)33917-9","volume":"92","author":"Fung","year":"1985","unstructured":"Fung WE (1985) Vitrectomy for chronic aphakic cystoid macular edema. Results of a national, collaborative, prospective, randomized investigation. Ophthalmology 92: 1102\u20131111","journal-title":"Ophthalmology"},{"key":"1534_CR14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0002-9394(14)74988-8","volume":"100","author":"Gass","year":"1985","unstructured":"Gass JD, Anderson DR, Davis EB (1985) A clinical, fluorescein angiographic, and electron microscopic correlation of cystoid macular edema. Am J Ophthalmol 100: 82\u201386","journal-title":"Am J Ophthalmol"},{"key":"1534_CR15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archopht.1966.03850010648005","volume":"76","author":"Gass","year":"1966","unstructured":"Gass JD, Norton EW (1966) Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol 76: 646\u2013661","journal-title":"Arch Ophthalmol"},{"key":"1534_CR16","first-page":"232","volume":"64","author":"Gass","year":"1966","unstructured":"Gass JD, Norton EW (1966) Fluorescein studies of patients with macular edema and papilledema following cataract extraction. Trans Am Ophthalmol Soc 64: 232\u2013249","journal-title":"Trans Am Ophthalmol Soc"},{"key":"1534_CR17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archopht.1968.00980050628009","volume":"80","author":"Gehring","year":"1968","unstructured":"Gehring JR (1968) Macular edema following cataract extraction. Arch Ophthalmol 80: 626\u2013631","journal-title":"Arch Ophthalmol"},{"key":"1534_CR18","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/01.iae.0000247165.38655.bf","volume":"26","author":"Haritoglou","year":"2006","unstructured":"Haritoglou C, Kook D, Neubauer A et al. (2006) Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26: 999\u20131005","journal-title":"Retina"},{"key":"1534_CR19","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0161-6420(00)00365-1","volume":"107","author":"Heier","year":"2000","unstructured":"Heier JS, Topping TM, Baumann W et al. (2000) Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology 107: 2034\u20132038","journal-title":"Ophthalmology"},{"key":"1534_CR20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/bjo.61.10.628","volume":"61","author":"Hitchings","year":"1977","unstructured":"Hitchings RA (1977) Aphakic macular oedema: a two-year follow-up study. Br J Ophthalmol 61: 628\u2013630","journal-title":"Br J Ophthalmol"},{"key":"1534_CR21","first-page":"499","volume":"36","author":"Irvine","year":"1953","unstructured":"Irvine SR (1953) A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol 36: 499\u2013619","journal-title":"Am J Ophthalmol"},{"key":"1534_CR22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/eye.2001.9","volume":"15","author":"Jain","year":"2001","unstructured":"Jain R, Stevens JD, Bunce CV et al. (2001) Ischaemic heart disease may predispose to pseudophakic cystoid macular oedema. Eye 15: 34\u201338","journal-title":"Eye"},{"key":"1534_CR23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00347-006-1355-2","volume":"103","author":"Jaissle","year":"2006","unstructured":"Jaissle GB, Ziemssen F, Petermeier K et al. (2006) Bevacizumab for treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe 103: 471\u2013475","journal-title":"Ophthalmologe"},{"key":"1534_CR24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archopht.121.5.729","volume":"121","author":"Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Degenring R (2003) Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol 121: 729\u2013730","journal-title":"Arch Ophthalmol"},{"key":"1534_CR25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9394(03)00230-7","volume":"136","author":"Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Degenring RF (2003) Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 136: 384\u2013386","journal-title":"Am J Ophthalmol"},{"key":"1534_CR26","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0161-6420(82)34710-7","volume":"89","author":"Kraff","year":"1982","unstructured":"Kraff MC, Sanders DR, Jampol LM et al. (1982) Prophylaxis of pseudophakic cystoid macular edema with topical indomethacin. Ophthalmology 89: 885\u2013890","journal-title":"Ophthalmology"},{"key":"1534_CR27","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00417-006-0326-2","volume":"244","author":"Kube","year":"2006","unstructured":"Kube T, Sutter M, Trittler R et al. (2006) Carboxymethylcellulose as a new carrier substance for intravitreal injection of reproducible amounts of triamcinolone. Graefes Arch Clin Exp Ophthalmol 244: 1385\u20131390","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1534_CR28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0002-9394(77)90737-1","volume":"83","author":"Martin","year":"1977","unstructured":"Martin NF, Green WR, Martin LW (1977) Retinal phlebitis in the Irvine-Gass syndrome. Am J Ophthalmol 83: 377\u2013386","journal-title":"Am J Ophthalmol"},{"key":"1534_CR29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00006982-200603000-00018","volume":"26","author":"Mason","year":"2006","unstructured":"Mason JO III, Albert MA Jr, Vail R (2006) Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina 26: 356\u2013357","journal-title":"Retina"},{"key":"1534_CR30","doi-asserted-by":"crossref","unstructured":"Melo GB, Farah ME, Aggio FB (2007) Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosa. Acta Ophthalmol Scand, doi:10.1111\/j.1600-0420.2006.00872.x","DOI":"10.1111\/j.1600-0420.2006.00872.x"},{"key":"1534_CR31","first-page":"146","volume":"29","author":"Miyake","year":"1985","unstructured":"Miyake K (1985) Vitreous fluorophotometry in aphakic or pseudophakic eyes with persistent cystoid macular edema. Jpn J Ophthalmol 29: 146\u2013152","journal-title":"Jpn J Ophthalmol"},{"key":"1534_CR32","first-page":"S203","volume":"Ophthalmol","author":"Miyake","year":"2002","unstructured":"Miyake K, Ibaraki N (2002) Prostaglandins and cystoid macular edema. Surv Ophthalmol (Suppl 1) 47: S203\u2013S218","journal-title":"Surv"},{"key":"1534_CR33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archopht.119.3.387","volume":"119","author":"Miyake","year":"2001","unstructured":"Miyake K, Ota I, Ibaraki N et al. (2001) Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol 119: 387\u2013394","journal-title":"Arch Ophthalmol"},{"key":"1534_CR34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archopht.117.1.34","volume":"117","author":"Miyake","year":"1999","unstructured":"Miyake K, Ota I, Maekubo K et al. (1999) Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch Ophthalmol 117: 34\u201340","journal-title":"Arch Ophthalmol"},{"key":"1534_CR35","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s004170050175","volume":"236","author":"Moldow","year":"1998","unstructured":"Moldow B, Sander B, Larsen M et al. (1998) The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema. Graefes Arch Clin Exp Ophthalmol 236: 881\u2013889","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1534_CR36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00175922","volume":"230","author":"Peterson","year":"1992","unstructured":"Peterson M, Yoshizumi MO, Hepler R et al. (1992) Topical indomethacin in the treatment of chronic cystoid macular edema. Graefes Arch Clin Exp Ophthalmol 230: 401\u2013405","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1534_CR37","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcrs.2004.12.067","volume":"31","author":"Reis","year":"2005","unstructured":"Reis A, Birnbaum F, Hansen LL et al. (2005) Cyclooxygenase-2 inhibitors: a new therapeutic option in the treatment of macular edema after cataract surgery. J Cataract Refract Surg 31: 1437\u20131440","journal-title":"J Cataract Refract Surg"},{"key":"1534_CR38","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/S0886-3350(03)00233-5","volume":"29","author":"Rho","year":"2003","unstructured":"Rho DS (2003) Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac. J Cataract Refract Surg 29: 2378\u20132384","journal-title":"J Cataract Refract Surg"},{"key":"1534_CR39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0886-3350(01)01079-3","volume":"28","author":"Rossetti","year":"2002","unstructured":"Rossetti A, Doro D (2002) Retained intravitreal lens fragments after phacoemulsification: complications and visual outcome in vitrectomized and nonvitrectomized eyes. J Cataract Refract Surg 28: 310\u2013315","journal-title":"J Cataract Refract Surg"},{"key":"1534_CR40","first-page":"493","volume":"Ophthalmol","author":"Sebag","year":"1984","unstructured":"Sebag J, Balazs EA (1984) Pathogenesis of cystoid macular edema: an anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol (Suppl) 28: 493\u2013498","journal-title":"Surv"},{"key":"1534_CR41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0886-3350(13)80484-1","volume":"21","author":"Solomon","year":"1995","unstructured":"Solomon LD (1995) Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Flurbiprofen-CME Study Group I. J Cataract Refract Surg 21: 73\u201381","journal-title":"J Cataract Refract Surg"},{"key":"1534_CR42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bjo.86.5.565","volume":"86","author":"Squirrell","year":"2002","unstructured":"Squirrell D, Bhola R, Bush J et al. (2002) A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol 86: 565\u2013571","journal-title":"Br J Ophthalmol"},{"key":"1534_CR43","doi-asserted-by":"crossref","unstructured":"Stahl A, Agostini HT, Hansen LL et al. (2007) Bevacizumab in retinal vein occlusion \u2013 results of a prospective case follow-up study. Graefes Arch Clin Exp Opthalmol [Epub ahead of print]","DOI":"10.1007\/s00417-007-0569-6"},{"key":"1534_CR44","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0002-9394(14)76242-7","volume":"112","author":"Steinert","year":"1991","unstructured":"Steinert RF, Puliafito CA, Kumar SR et al. (1991) Cystoid macular edema, retinal detachment, and glaucoma after Nd:YAG laser posterior capsulotomy. Am J Ophthalmol 112: 373\u2013380","journal-title":"Am J Ophthalmol"},{"key":"1534_CR45","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0161-6420(81)80009-7","volume":"88","author":"Stern","year":"1981","unstructured":"Stern AL, Taylor DM, Dalburg LA et al. (1981) Pseudophakic cystoid maculopathy: a study of 50 cases. Ophthalmology 88: 942\u2013946","journal-title":"Ophthalmology"},{"key":"1534_CR46","unstructured":"Wenzel M, Pham DT, Reuscher A et al. (2006) Derzeitiger Stand der Katarakt und refraktiven Chirurgie. Ophthalmo-Chirurgie 18: 207\u2013215"},{"key":"1534_CR47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00414576","volume":"216","author":"Wolter","year":"1981","unstructured":"Wolter JR (1981) The histopathology of cystoid macular edema. Albrecht Von Graefes Arch Klin Exp Ophthalmol 216: 85\u2013101","journal-title":"Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"1534_CR48","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0002-9394(77)90444-5","volume":"84","author":"Yannuzzi","year":"1977","unstructured":"Yannuzzi LA, Klein RM, Wallyn RH et al. (1977) Ineffectiveness of indomethacin in the treatment of chronic cystoid macular edema. Am J Ophthalmol 84: 517\u2013519","journal-title":"Am J Ophthalmol"},{"key":"1534_CR49","doi-asserted-by":"crossref","unstructured":"Ziemssen F, Deuter CM, Stuebiger N et al. (2007) Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin). Graefes Arch Clin Exp Ophthalmol [Epub ahead of print]","DOI":"10.1007\/s00417-006-0512-2"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-007-1534-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-007-1534-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-007-1534-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:50:48Z","timestamp":1559051448000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-007-1534-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["1534"],"URL":"https:\/\/doi.org\/10.1007\/s00347-007-1534-9","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}